Jefferies Group's CAI Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 10,745 shares of Caris Life Sciences, Inc. (CAI) worth $192,121, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in CAI, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Caris Life Sciences (CAI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Caris Life Sciences (CAI) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +10,745 | New Buy | 10,745 | $17.88 |
Jefferies Group's Caris Life Sciences Investment FAQs
Jefferies Group first purchased Caris Life Sciences, Inc. (CAI) in Q1 2026, acquiring 10,745 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Caris Life Sciences, Inc. (CAI) for 1 quarters since Q1 2026.
Jefferies Group's largest addition to Caris Life Sciences, Inc. (CAI) was in Q1 2026, adding 10,745 shares worth $192,121.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 10,745 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $192,121.
As of the Q1 2026 filing, Caris Life Sciences, Inc. (CAI) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Caris Life Sciences, Inc. (CAI) was 10,745 shares, as reported at the end of Q1 2026.